Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation
2020 · Biomedicine & Pharmacotherapy · 73 citations
https://doi.org/10.1016/j.biopha.2019.109810
M
Mingjun Zheng
LMU Klinikum(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
1.4K
Citations
22
h-index
37
i10-index
Mingjun Zheng is an academic researcher from LMU Klinikum. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Ferroptosis and cancer prognosis & Circular RNAs in diseases. The author has an h-index of 22, co-authored 67 publications.
Papers by this author
worksIdentification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
2021 · BMC Medicine · 64 citations
https://doi.org/10.1186/s12916-021-02031-3
Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
2019 · Journal of Translational Medicine · 61 citations
https://doi.org/10.1186/s12967-019-2023-z
A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
2022 · Genome Medicine · 56 citations
https://doi.org/10.1186/s13073-022-01024-y
Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer
2019 · Journal of Translational Medicine · 37 citations
https://doi.org/10.1186/s12967-019-02140-x
Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing
2023 · Oxidative Medicine and Cellular Longevity · 27 citations
https://doi.org/10.1155/2023/1261039
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat